Arkolith/Insider Trading/RPHM/Form 4

Novo Holdings A/S

10% OwnerReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed Jun 23, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$710K
Net Open-Market Flow
-$710K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2023Sell(S)100K$7.10$710K3.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-039541) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML